NMS-01940153E
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NMS-01940153E, covering 2025-05-07 to 2025-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy [Phase 1, Phase 2]